Circulating PCSK9 is a strong determinant of plasma triacylglycerols and total cholesterol in homozygous carriers of apolipoprotein ε2

Martijn C. G. J. Brouwers*, Marleen M. J. van Greevenbroek, Robert J. Konrad, Jason. S. Troutt, Nicolaas C. Schaper, Coen D. A. Stehouwer

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

9 Citations (Web of Science)
Original languageEnglish
Pages (from-to)679-684
JournalClinical Science
Issue number9
Publication statusPublished - May 2014


  • apolipoprotein E
  • familial dysbetalipoproteinaemia
  • type III hyperlipidaemia
  • familial combined hyperlipidaemia (FCHL)
  • pro-protein convertase subtilisin kexin type 9 (PCSK9)
  • remnant particle

Cite this